SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-026182
Filing Date
2022-02-23
Accepted
2022-02-23 17:15:54
Documents
1
Period of Report
2022-02-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm225222-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm225222-5_4seq1.xml 4 3281
  Complete submission text file 0001104659-22-026182.txt   4680
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR NEW YORK NY 10169
Business Address
Kruse Bo (Reporting) CIK: 0001752940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 22665009